GeneReach Biotechnology Statistics

Total Valuation

TPEX:4171 has a market cap or net worth of TWD 1.15 billion. The enterprise value is 918.26 million.

Market Cap	1.15B
Enterprise Value	918.26M

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4171 has 57.46 million shares outstanding. The number of shares has decreased by -0.30% in one year.

Current Share Class	n/a
Shares Outstanding	57.46M
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	-0.69%
Owned by Insiders (%)	5.31%
Owned by Institutions (%)	0.49%
Float	42.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.55
PB Ratio	1.58
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.73
EV / Sales	4.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.26

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.37.

Current Ratio	2.48
Quick Ratio	2.30
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-8.81
Interest Coverage	-22.11

Financial Efficiency

Return on equity (ROE) is -15.58% and return on invested capital (ROIC) is -7.80%.

Return on Equity (ROE)	-15.58%
Return on Assets (ROA)	-7.31%
Return on Invested Capital (ROIC)	-7.80%
Return on Capital Employed (ROCE)	-15.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.18
Inventory Turnover	1.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.27% in the last 52 weeks. The beta is 0.27, so TPEX:4171's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-39.27%
50-Day Moving Average	22.69
200-Day Moving Average	28.07
Relative Strength Index (RSI)	45.72
Average Volume (20 Days)	147,733

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4171 had revenue of TWD 206.49 million and -118.73 million in losses. Loss per share was -2.07.

Revenue	206.49M
Gross Profit	118.28M
Operating Income	-131.22M
Pretax Income	-116.98M
Net Income	-118.73M
EBITDA	-56.48M
EBIT	-131.22M
Loss Per Share	-2.07

Full Income Statement

Balance Sheet

The company has 503.76 million in cash and 267.23 million in debt, giving a net cash position of 236.53 million or 4.12 per share.

Cash & Cash Equivalents	503.76M
Total Debt	267.23M
Net Cash	236.53M
Net Cash Per Share	4.12
Equity (Book Value)	725.49M
Book Value Per Share	12.56
Working Capital	355.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.22 million and capital expenditures -7.12 million, giving a free cash flow of -30.35 million.

Operating Cash Flow	-23.22M
Capital Expenditures	-7.12M
Free Cash Flow	-30.35M
FCF Per Share	-0.53

Full Cash Flow Statement

Margins

Gross margin is 57.28%, with operating and profit margins of -63.55% and -57.50%.

Gross Margin	57.28%
Operating Margin	-63.55%
Pretax Margin	-56.65%
Profit Margin	-57.50%
EBITDA Margin	-27.35%
EBIT Margin	-63.55%
FCF Margin	n/a

Dividends & Yields

TPEX:4171 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.30%
Shareholder Yield	0.30%
Earnings Yield	-10.36%
FCF Yield	-2.65%

Dividend Details

Stock Splits

The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.

Last Split Date	Jul 28, 2023
Split Type	Forward
Split Ratio	1.25

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a